Cardiovascular

Irbefutal
  • Active Substance (s) : Irbesartan 150, 300 mg
  • Dosage Form : Tablets
  • Pack : 7 tablets/ blister
  • Indication :
    • Treatment of Essential hypertension, Renal disease in adult patients with hypertension and Type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen
  • Product Description : Irbefutal lowers blood pressure with minimal change in heart rate Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. Irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria
  • Recommended Daily Dosage :
    • The usual recommended initial and maintenance dose is 150 mg once daily, with or without food